118 related articles for article (PubMed ID: 24295148)
1. Evidence is not sufficient to recommend a more aggressive approach to familial nonmedullary thyroid cancer.
Benbassat C
Thyroid; 2014 Apr; 24(4):781-2. PubMed ID: 24295148
[No Abstract] [Full Text] [Related]
2. Is familial nonmedullary thyroid carcinoma more aggressive than sporadic nonmedullary thyroid carcinoma?
Malchoff CD; McDonald TJ
Thyroid; 2014 Apr; 24(4):782-3. PubMed ID: 24494807
[No Abstract] [Full Text] [Related]
3. Aggressiveness in familial nonmedullary thyroid carcinoma--the controversy continues.
Mazeh H; Sippel RS
Thyroid; 2014 Apr; 24(4):783-4. PubMed ID: 24660808
[No Abstract] [Full Text] [Related]
4. Familial nonmedullary thyroid cancer: an emerging entity that warrants aggressive treatment.
Takami H; Ozaki O; Ito K
Arch Surg; 1996 Jun; 131(6):676. PubMed ID: 8645080
[No Abstract] [Full Text] [Related]
5. Familial nonmedullary thyroid carcinoma.
Malchoff CD; Malchoff DM
Semin Surg Oncol; 1999; 16(1):16-8. PubMed ID: 9890735
[TBL] [Abstract][Full Text] [Related]
6. Familial nonmedullary thyroid carcinoma.
Mazeh H; Sippel RS
Thyroid; 2013 Sep; 23(9):1049-56. PubMed ID: 23734600
[TBL] [Abstract][Full Text] [Related]
7. [Familial nonmedullary thyroid cancer].
Sugino K; Mimura T; Ito K; Ito K
Nihon Rinsho; 2000 Jul; 58(7):1519-22. PubMed ID: 10921335
[TBL] [Abstract][Full Text] [Related]
8. [Familial nommedullary thyroid cancer].
Santos RB; Melo TG; Assumpção LV
Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):769-73. PubMed ID: 17891240
[TBL] [Abstract][Full Text] [Related]
9. The incidence of familial nonmedullary thyroid cancer in a large case series.
Zivaljevic V; Paunovic I; Diklic A; Krgovic K; Kalezic N; Kazic M; Tatic S; Savic D; Stojanovic D; Perunovic R
Acta Chir Belg; 2008; 108(3):328-32. PubMed ID: 18710108
[TBL] [Abstract][Full Text] [Related]
10. [Follicular cell (papillary and follicular) thyroid carcinoma, genetic inheritance, and molecular diagnostic markers].
Kazubskaia TP; Kozlova VM; Kondrat'eva TT; Pavlovskaia AI; Marakhonov AV; Baranova AV; Ivanova NI; Stepanova AA; Poliakov AV; Belev NF; Brzhezovskiĭ VZh
Arkh Patol; 2014; 76(5):3-12. PubMed ID: 25543402
[TBL] [Abstract][Full Text] [Related]
11. Familial nonmedullary thyroid neoplasia.
Rubén Harach H
Endocr Pathol; 2001; 12(2):97-112. PubMed ID: 11579685
[TBL] [Abstract][Full Text] [Related]
12. Thyroid cancer of follicular cell origin in inherited tumor syndromes.
Nosé V
Adv Anat Pathol; 2010 Nov; 17(6):428-36. PubMed ID: 20966648
[TBL] [Abstract][Full Text] [Related]
13. Identification of Unique, Heterozygous Germline Mutation, STK11 (p.F354L), in a Child with an Encapsulated Follicular Variant of Papillary Thyroid Carcinoma within Six Months of Completing Treatment for Neuroblastoma.
Buryk MA; Picarsic JL; Creary SE; Shaw PH; Simons JP; Deutsch M; Monaco SE; Nikiforov YE; Witchel SF
Pediatr Dev Pathol; 2015; 18(4):318-23. PubMed ID: 25751324
[TBL] [Abstract][Full Text] [Related]
14. Familial non-medullary thyroid cancer in Iceland.
Hrafnkelsson J; Tulinius H; Jónasson JG; Sigvaldason H
J Med Genet; 2001 Mar; 38(3):189-91. PubMed ID: 11303513
[No Abstract] [Full Text] [Related]
15. Cribriform-morular variant of papillary thyroid carcinoma displaying poorly differentiated features.
Nakazawa T; Celestino R; Machado JC; Cameselle-Teijeiro JM; Vinagre J; Eloy C; Benserai F; Lameche S; Soares P; Sobrinho-Simões M
Int J Surg Pathol; 2013 Aug; 21(4):379-89. PubMed ID: 23349472
[TBL] [Abstract][Full Text] [Related]
16. Genetic mutations in thyroid carcinoma.
Taccaliti A; Boscaro M
Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
[TBL] [Abstract][Full Text] [Related]
17. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population.
Uchino S; Noguchi S; Kawamoto H; Yamashita H; Watanabe S; Yamashita H; Shuto S
World J Surg; 2002 Aug; 26(8):897-902. PubMed ID: 11965446
[TBL] [Abstract][Full Text] [Related]
18. RAS mutations in indeterminate thyroid nodules are predictive of the follicular variant of papillary thyroid carcinoma.
An JH; Song KH; Kim SK; Park KS; Yoo YB; Yang JH; Hwang TS; Kim DL
Clin Endocrinol (Oxf); 2015 May; 82(5):760-6. PubMed ID: 25109485
[TBL] [Abstract][Full Text] [Related]
19. A Greek family with a follicular variant of familial papillary thyroid carcinoma: TCO, MNG1, fPTC/PRN, and NMTC1 excluded as susceptibility loci.
Tsilchorozidou T; Vafiadou E; Yovos JG; Romeo G; McKay J; Lesueur F; Bonora E
Thyroid; 2005 Dec; 15(12):1349-54. PubMed ID: 16405407
[TBL] [Abstract][Full Text] [Related]
20. TROP-2 expression in papillary thyroid cancer: a preliminary cyto-histological study.
Addati T; Achille G; Centrone M; Petroni S; Popescu O; Russo S; Grammatica L; Simone G
Cytopathology; 2015 Oct; 26(5):303-11. PubMed ID: 25164548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]